Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Nature Communications|February 17, 2021
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cellsRebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye, et al.
Cancer Research|September 19, 2018
Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell CarcinomaJason R Baird, R Bryan Bell, Victoria Troesch, et al.
Head & Neck|August 25, 2025
Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaDavid M Cognetti, Joseph M Curry, Jennifer Johnson, et al.
Oral Oncology|October 10, 2022
Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neckBrian J Park, Austin K Mattox, Daniel Clayburgh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2021
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)Robert L Ferris, Yael Flamand, Gregory S Weinstein, et al.
Journal for Immunotherapy of Cancer|July 17, 2019
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)Ezra E W Cohen, R Bryan Bell, Carlo B Bifulco, et al.
JCI Insight|June 30, 2026
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcomaJianguo Huang, Xingliang Liu, Warren Floyd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2025
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx CancerBarbara Burtness, Yael Flamand, Harry Quon, et al.
JCO Oncology Advances|April 2, 2026
Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311Katherine A Hutcheson, Yael Flamand, Beatrice Manduchi, et al.
Nature Communications|July 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapyRobert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang, et al.
Pageof 11